Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

IDH1 and IDH2 Mutations Confer An Adverse Effect In Patients With Acute Myeloid Leukemia Lacking The NPM1 Mutation

Shunichiro Yamaguchi, MD, Eisaku Iwanaga, MD, PhD, Kenji Tokunaga, MD, Tomoko Nanri, MD, PhD, Taizo Shimomura, MD, PhD, Hitoshi Suzushima, MD, PhD, Yutaka Okuno, MD, PhD, Hiroaki Mitsuya, MD, PhD, Norio Asou, MD, PhD

Blood (2013) 122 (21): 4977.

https://doi.org/10.1182/blood.V122.21.4977.4977

Published: 2013

Journal Articles

Crebbp HAT Domain Mutations Are Frequently Detected in Adult Acute Lymphoblastic Leukemia

Kenji Tokunaga, MD, Shunichiro Yamaguchi, MD, Eisaku Iwanaga, MD, PhD, Tomoko Nanri, MD, PhD, Taizo Shimomura, MD, PhD, Hitoshi Suzushima, MD, PhD, Mitsuya Hiroaki, MD, PhD, Norio Asou, MD, PhD

Blood (2012) 120 (21): 1419.

https://doi.org/10.1182/blood.V120.21.1419.1419

Published: 2012

Journal Articles

Prognostic Impact and Concurrent Genetic Alterations of CEBPA Double Mutations in Adults with Cytogenetically Intermediate-Risk Acute Myeloid Leukemia.

Shunichiro Yamaguchi, MD, Kenji Tokunaga, MD, Eisaku Iwanaga, MD, PhD, Tomoko Nanri, MD, PhD, Taizo Shimomura, MD, PhD, Hitoshi Suzushima, MD, PhD, Hiroaki Mitsuya, Norio Asou, MD, PhD

Blood (2012) 120 (21): 2538.

https://doi.org/10.1182/blood.V120.21.2538.2538

Published: 2012

Journal Articles

IDH2 Mutations Have An Unfavorable Impact in Elderly Patients with Acute Myeloid Leukemia

Shunichro Yamaguchi, MD, Eisaku Iwanaga, MD, Kenji Tokunaga, MD, Tomoko Nanri, MD, PhD, Hitoshi Suzushima, MD, PhD, Taizo Shimomura, MD, PhD, Hiroaki Mitsuya, MD, PhD, Norio Asou, MD, PhD

Blood (2011) 118 (21): 2519.

https://doi.org/10.1182/blood.V118.21.2519.2519

Published: 2011

Journal Articles

A JAK2-V617F Activating Mutation in Addition to C-KIT and FLT3 Mutations Is Associated with Clinical Outcome in Patients with t(8;21)(q22;q22;) Acute Myeloid Leukemia.

Tomoko Nanri, MD, PhD, Eisaku Iwanaga, MD, Naofumi Matsuno, MD, PhD, Toshiro Kawakita, MD, Hitoshi Suzushima, MD, PhD, Fumio Kawano, MD, PhD, Hiroaki Mitsuya, MD, PhD, Norio Asou, MD, PhD

Blood (2007) 110 (11): 3492.

https://doi.org/10.1182/blood.V110.11.3492.3492

Published: 2007

Journal Articles

A Pedigree Harboring a Germ-Line N-Terminal C/EBPα Mutation and Development of Acute Myeloblastic Leukemia with a Somatic C-Terminal C/EBPα Mutation.

Tomoko Nanri, MD, Naokuni Uike, MD, Toshiro Kawakita, MD, Eisaku Iwanaga, MD, Koyu Hoshino, MD, Hiroaki Mitsuya, MD, Norio Asou, MD

Blood (2006) 108 (11): 1916.

https://doi.org/10.1182/blood.V108.11.1916.1916

Published: 2006

Journal Articles

Familial Acute Myeloblastic Leukemia with a Dominant Negative Mutation in the CEBPA Gene.

Tomoko Nanri, MD, Toshiro Kawakita, MD, Koyu Hoshino, MD, PhD, Hiroaki Mitsuya, MD, PhD, Norio Asou, MD, PhD, Naokuni Uike, MD

Blood (2005) 106 (11): 4564.

https://doi.org/10.1182/blood.V106.11.4564.4564

Published: 2005

Journal Articles

Mutations in the Receptor Tyrosine Kinase Pathway Are Associated with Clinical Outcome in Patients with Acute Myeloblastic Leukemia Harboring t(8;21)(q22;q22).

Tomoko Nanri, MD, Naofumi Matsuno, MD, Toshiro Kawakita, MD, Hitoshi Suzushima, MD, Fumio Kawano, MD, Hiroaki Mitsuya, MD, Norio Asou, MD

Blood (2004) 104 (11): 3000.

https://doi.org/10.1182/blood.V104.11.3000.3000

Published: 2004

NARROW

IDH1 and IDH2 Mutations Confer An Adverse Effect In Patients With Acute Myeloid Leukemia Lacking The NPM1 Mutation

Crebbp HAT Domain Mutations Are Frequently Detected in Adult Acute Lymphoblastic Leukemia

Prognostic Impact and Concurrent Genetic Alterations of CEBPA Double Mutations in Adults with Cytogenetically Intermediate-Risk Acute Myeloid Leukemia.

IDH2 Mutations Have An Unfavorable Impact in Elderly Patients with Acute Myeloid Leukemia

A JAK2-V617F Activating Mutation in Addition to C-KIT and FLT3 Mutations Is Associated with Clinical Outcome in Patients with t(8;21)(q22;q22;) Acute Myeloid Leukemia.

A Pedigree Harboring a Germ-Line N-Terminal C/EBPα Mutation and Development of Acute Myeloblastic Leukemia with a Somatic C-Terminal C/EBPα Mutation.

Familial Acute Myeloblastic Leukemia with a Dominant Negative Mutation in the CEBPA Gene.

Mutations in the Receptor Tyrosine Kinase Pathway Are Associated with Clinical Outcome in Patients with Acute Myeloblastic Leukemia Harboring t(8;21)(q22;q22).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only